Mechanisms of the contractile effects of 2,3-butanedione-monoxime in the mammalian heart

N. Zimmermann, P. Boknik, E. Gams, S. Gsell, Larry Jones, R. Maas, J. Neumann, H. Scholz

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

We studied the mechanisms of action of a negative inotropic compound, 2,3-butanedione-monoxime (BDM), which has been suggested to be a cardioprotective agent. In guinea-pig papillary muscles the negative inotropic effect of BDM started at 100 μmol/l amounting to 18.32 ± 2.09% of predrug value at 10 mmol/l without any effects on time parameters (n = 12, each). 30 mmol/l BDM totally abolished force of contraction; this effect was reversible after washout. In the presence of the phosphatase-inhibitor cantharidin (30 μmol/l) the concentration response curve on force of contraction was shifted to higher concentrations of BDM. 100 mmol/l BDM decreased the phosphorylation state of the inhibitory subunit of troponin (TnI) and phospholamban (PLB) in [32P]-labeled guinea-pig ventricular myocytes to 76.5 ± 4.7% and 49.7 ± 4.2%, respectively (n = 7). Furthermore, BDM enhanced the activity of phosphorylase phosphatases in guinea-pig ventricular homogenates amounting to a stimulation to 203.5 ± 10.4% at 100 mmol/l whereas type 1 phosphorylase phosphatase activity increased only by 24.5% (n = 5). PLB phosphatase activity was enhanced to 155.9 ± 11.7% by 100 mmol/l BDM (n = 5). It is concluded that the effects of BDM on contractile parameters are accompanied by decreased phosphorylation of the cardiac regulatory proteins TnI and PLB which could in part be due to activation of type 1 or 2A phosphatase activity. Hence, it is suggested that BDM affects the phosphorylation state of TnI and PLB not directly, but via activation of their phosphatases.

Original languageEnglish
Pages (from-to)431-436
Number of pages6
JournalNaunyn-Schmiedeberg's Archives of Pharmacology
Volume354
Issue number4
StatePublished - 1996

Fingerprint

Troponin
Phosphorylase Phosphatase
Phosphoric Monoester Hydrolases
Guinea Pigs
Phosphorylation
Cantharidin
Cardiotonic Agents
diacetylmonoxime
Papillary Muscles
Muscle Cells
phospholamban
Proteins

Keywords

  • 2,3-butanedione-monoxime
  • Inhibitory subunit of troponin
  • Negative inotropic effect
  • Phosphatase
  • Phospholamban
  • Phosphorylation

ASJC Scopus subject areas

  • Pharmacology

Cite this

Zimmermann, N., Boknik, P., Gams, E., Gsell, S., Jones, L., Maas, R., ... Scholz, H. (1996). Mechanisms of the contractile effects of 2,3-butanedione-monoxime in the mammalian heart. Naunyn-Schmiedeberg's Archives of Pharmacology, 354(4), 431-436.

Mechanisms of the contractile effects of 2,3-butanedione-monoxime in the mammalian heart. / Zimmermann, N.; Boknik, P.; Gams, E.; Gsell, S.; Jones, Larry; Maas, R.; Neumann, J.; Scholz, H.

In: Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 354, No. 4, 1996, p. 431-436.

Research output: Contribution to journalArticle

Zimmermann, N, Boknik, P, Gams, E, Gsell, S, Jones, L, Maas, R, Neumann, J & Scholz, H 1996, 'Mechanisms of the contractile effects of 2,3-butanedione-monoxime in the mammalian heart', Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 354, no. 4, pp. 431-436.
Zimmermann, N. ; Boknik, P. ; Gams, E. ; Gsell, S. ; Jones, Larry ; Maas, R. ; Neumann, J. ; Scholz, H. / Mechanisms of the contractile effects of 2,3-butanedione-monoxime in the mammalian heart. In: Naunyn-Schmiedeberg's Archives of Pharmacology. 1996 ; Vol. 354, No. 4. pp. 431-436.
@article{bf5f7846fcbc40f1863f770f341c019a,
title = "Mechanisms of the contractile effects of 2,3-butanedione-monoxime in the mammalian heart",
abstract = "We studied the mechanisms of action of a negative inotropic compound, 2,3-butanedione-monoxime (BDM), which has been suggested to be a cardioprotective agent. In guinea-pig papillary muscles the negative inotropic effect of BDM started at 100 μmol/l amounting to 18.32 ± 2.09{\%} of predrug value at 10 mmol/l without any effects on time parameters (n = 12, each). 30 mmol/l BDM totally abolished force of contraction; this effect was reversible after washout. In the presence of the phosphatase-inhibitor cantharidin (30 μmol/l) the concentration response curve on force of contraction was shifted to higher concentrations of BDM. 100 mmol/l BDM decreased the phosphorylation state of the inhibitory subunit of troponin (TnI) and phospholamban (PLB) in [32P]-labeled guinea-pig ventricular myocytes to 76.5 ± 4.7{\%} and 49.7 ± 4.2{\%}, respectively (n = 7). Furthermore, BDM enhanced the activity of phosphorylase phosphatases in guinea-pig ventricular homogenates amounting to a stimulation to 203.5 ± 10.4{\%} at 100 mmol/l whereas type 1 phosphorylase phosphatase activity increased only by 24.5{\%} (n = 5). PLB phosphatase activity was enhanced to 155.9 ± 11.7{\%} by 100 mmol/l BDM (n = 5). It is concluded that the effects of BDM on contractile parameters are accompanied by decreased phosphorylation of the cardiac regulatory proteins TnI and PLB which could in part be due to activation of type 1 or 2A phosphatase activity. Hence, it is suggested that BDM affects the phosphorylation state of TnI and PLB not directly, but via activation of their phosphatases.",
keywords = "2,3-butanedione-monoxime, Inhibitory subunit of troponin, Negative inotropic effect, Phosphatase, Phospholamban, Phosphorylation",
author = "N. Zimmermann and P. Boknik and E. Gams and S. Gsell and Larry Jones and R. Maas and J. Neumann and H. Scholz",
year = "1996",
language = "English",
volume = "354",
pages = "431--436",
journal = "Naunyn-Schmiedeberg's Archives of Pharmacology",
issn = "0028-1298",
publisher = "Springer Verlag",
number = "4",

}

TY - JOUR

T1 - Mechanisms of the contractile effects of 2,3-butanedione-monoxime in the mammalian heart

AU - Zimmermann, N.

AU - Boknik, P.

AU - Gams, E.

AU - Gsell, S.

AU - Jones, Larry

AU - Maas, R.

AU - Neumann, J.

AU - Scholz, H.

PY - 1996

Y1 - 1996

N2 - We studied the mechanisms of action of a negative inotropic compound, 2,3-butanedione-monoxime (BDM), which has been suggested to be a cardioprotective agent. In guinea-pig papillary muscles the negative inotropic effect of BDM started at 100 μmol/l amounting to 18.32 ± 2.09% of predrug value at 10 mmol/l without any effects on time parameters (n = 12, each). 30 mmol/l BDM totally abolished force of contraction; this effect was reversible after washout. In the presence of the phosphatase-inhibitor cantharidin (30 μmol/l) the concentration response curve on force of contraction was shifted to higher concentrations of BDM. 100 mmol/l BDM decreased the phosphorylation state of the inhibitory subunit of troponin (TnI) and phospholamban (PLB) in [32P]-labeled guinea-pig ventricular myocytes to 76.5 ± 4.7% and 49.7 ± 4.2%, respectively (n = 7). Furthermore, BDM enhanced the activity of phosphorylase phosphatases in guinea-pig ventricular homogenates amounting to a stimulation to 203.5 ± 10.4% at 100 mmol/l whereas type 1 phosphorylase phosphatase activity increased only by 24.5% (n = 5). PLB phosphatase activity was enhanced to 155.9 ± 11.7% by 100 mmol/l BDM (n = 5). It is concluded that the effects of BDM on contractile parameters are accompanied by decreased phosphorylation of the cardiac regulatory proteins TnI and PLB which could in part be due to activation of type 1 or 2A phosphatase activity. Hence, it is suggested that BDM affects the phosphorylation state of TnI and PLB not directly, but via activation of their phosphatases.

AB - We studied the mechanisms of action of a negative inotropic compound, 2,3-butanedione-monoxime (BDM), which has been suggested to be a cardioprotective agent. In guinea-pig papillary muscles the negative inotropic effect of BDM started at 100 μmol/l amounting to 18.32 ± 2.09% of predrug value at 10 mmol/l without any effects on time parameters (n = 12, each). 30 mmol/l BDM totally abolished force of contraction; this effect was reversible after washout. In the presence of the phosphatase-inhibitor cantharidin (30 μmol/l) the concentration response curve on force of contraction was shifted to higher concentrations of BDM. 100 mmol/l BDM decreased the phosphorylation state of the inhibitory subunit of troponin (TnI) and phospholamban (PLB) in [32P]-labeled guinea-pig ventricular myocytes to 76.5 ± 4.7% and 49.7 ± 4.2%, respectively (n = 7). Furthermore, BDM enhanced the activity of phosphorylase phosphatases in guinea-pig ventricular homogenates amounting to a stimulation to 203.5 ± 10.4% at 100 mmol/l whereas type 1 phosphorylase phosphatase activity increased only by 24.5% (n = 5). PLB phosphatase activity was enhanced to 155.9 ± 11.7% by 100 mmol/l BDM (n = 5). It is concluded that the effects of BDM on contractile parameters are accompanied by decreased phosphorylation of the cardiac regulatory proteins TnI and PLB which could in part be due to activation of type 1 or 2A phosphatase activity. Hence, it is suggested that BDM affects the phosphorylation state of TnI and PLB not directly, but via activation of their phosphatases.

KW - 2,3-butanedione-monoxime

KW - Inhibitory subunit of troponin

KW - Negative inotropic effect

KW - Phosphatase

KW - Phospholamban

KW - Phosphorylation

UR - http://www.scopus.com/inward/record.url?scp=0029815849&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029815849&partnerID=8YFLogxK

M3 - Article

C2 - 8897445

AN - SCOPUS:0029815849

VL - 354

SP - 431

EP - 436

JO - Naunyn-Schmiedeberg's Archives of Pharmacology

JF - Naunyn-Schmiedeberg's Archives of Pharmacology

SN - 0028-1298

IS - 4

ER -